Pieris Pharmaceuticals Price to Sales Ratio 1970-1969 | PVLA
Historical PS ratio values for Pieris Pharmaceuticals (PVLA) over the last 10 years. The current P/S ratio for Pieris Pharmaceuticals as of December 20, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Pieris Pharmaceuticals P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2024-12-20 |
12.05 |
|
inf |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.016B |
$0.043B |
|
Pieris Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's drug technology consists of Anticalin(R) to treat cancer, severe asthma, anemia and other medical conditions. Pieris Pharmaceuticals, Inc. is based in Freising-Weihenstephan, Germany.
|
